REMOSENSE PUMP FOR REMODULIN (TREPROSTINIL) INJECTION Trademark

Trademark Overview

On Wednesday, January 11, 2023, a trademark application was filed for REMOSENSE PUMP FOR REMODULIN (TREPROSTINIL) INJECTION with the United States Patent and Trademark Office. The USPTO has given the REMOSENSE PUMP FOR REMODULIN (TREPROSTINIL) INJECTION trademark a serial number of 97750666. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Thursday, July 17, 2025. This trademark is owned by United Therapeutics Corporation. The REMOSENSE PUMP FOR REMODULIN (TREPROSTINIL) INJECTION trademark is filed in the Medical Instrument Products category with the following description:

Drug delivery systems sold empty, namely, drug delivery pumps
remosense pump for remodulin (treprostinil) injection

General Information

Serial Number97750666
Word MarkREMOSENSE PUMP FOR REMODULIN (TREPROSTINIL) INJECTION
Filing DateWednesday, January 11, 2023
Status733 - FOURTH EXTENSION - GRANTED
Status DateThursday, July 17, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 30, 2023

Trademark Statements

NOT AVAILABLE"PUMP" AND "(TREPROSTINIL) INJECTION"
Goods and ServicesDrug delivery systems sold empty, namely, drug delivery pumps

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, February 2, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameUnited Therapeutics Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSilver Spring, MD 20910
Party NameUnited Therapeutics Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSilver Spring, MD 20910

Trademark Events

Event DateEvent Description
Saturday, January 14, 2023NEW APPLICATION ENTERED
Thursday, February 2, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 13, 2023ASSIGNED TO EXAMINER
Friday, April 21, 2023EXAMINERS AMENDMENT -WRITTEN
Friday, April 21, 2023EXAMINERS AMENDMENT E-MAILED
Friday, April 21, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, April 21, 2023EXAMINER'S AMENDMENT ENTERED
Friday, April 21, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 10, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 30, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 30, 2023PUBLISHED FOR OPPOSITION
Tuesday, July 25, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 3, 2024SOU EXTENSION 1 FILED
Wednesday, January 3, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 3, 2024SOU EXTENSION 1 GRANTED
Tuesday, July 23, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 23, 2024SOU EXTENSION 2 FILED
Tuesday, July 23, 2024SOU EXTENSION 2 GRANTED
Wednesday, July 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 24, 2025SOU TEAS EXTENSION RECEIVED
Friday, January 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, January 25, 2025SOU EXTENSION 3 GRANTED
Tuesday, March 4, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 17, 2025SOU TEAS EXTENSION RECEIVED
Thursday, July 17, 2025SOU EXTENSION 4 FILED
Thursday, July 17, 2025SOU EXTENSION 4 GRANTED
Thursday, July 17, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 24, 2025SOU EXTENSION 3 FILED

Related Keywords

injection treprostinil remodulin pump remosense drug delivery namely pumps sold systems empty